Pressmeddelanden från PCI Biotech

Bevaka pressreleaser

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Minutes from Extraordinary General Meeting 23 feb 13:17

Notice of Extraordinary General Meeting, proposed company dissolution and delisting 29 jan 17:50

PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process 08 jan 14:10

PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options 23 okt 2025 10:35

PCI Biotech update 25 sep 2025 15:36

PCI Biotech update on future operations 29 aug 2025 07:00

PCI Biotech half-year interim 2025 report 26 aug 2025 16:15

PCI Biotech: Invitation to first half 2025 results presentation and corporate update 22 aug 2025 14:15

Flaggemelding 22 aug 2025 11:09

Flaggemelding 18 aug 2025 20:40

PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations 22 maj 2025 11:45

PCI Biotech: Minutes of Annual General Meeting 2025 20 maj 2025 22:09

PCI BIotech: Disclosure of voting rights for Chair of the Board 30 apr 2025 10:00

Notice of Annual General Meeting 2025 24 apr 2025 17:31

PCI Biotech Holding ASA: Annual Report 2024 27 feb 2025 07:00

PCI Biotech full year 2024 interim results 25 feb 2025 08:56

PCI Biotech: Invitation to preliminary full-year 2024 results presentation 10 jan 2025 10:24

PCI Biotech: Employee share option scheme in connection with promotion of new CSO 02 sep 2024 07:53

PCI Biotech: Employee share option scheme 28 aug 2024 07:00

PCI Biotech first half 2024 interim results 23 aug 2024 09:36

PCI Biotech: Invitation to first half interim 2024 results presentation 24 maj 2024 12:30

Minutes of Annual General Meeting 2024 23 maj 2024 09:03

Disclosure of voting rights for Chair of the Board 03 maj 2024 10:00

PCI Biotech Holding ASA - Notice of Annual General Meeting 2024 26 apr 2024 08:08

PCI Biotech Holding ASA - Annual Report 2023 14 feb 2024 07:00

PCI Biotech second half 2023 interim results 12 feb 2024 09:26

PCI Biotech: Invitation to second half interim 2023 results presentation 13 okt 2023 10:17

PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing 07 sep 2023 12:36

PCI Biotech: European patent for mRNA delivery with fimaNAc 04 sep 2023 10:14

PCI Biotech: Employee share option scheme 01 sep 2023 11:04

PCI Biotech: Write-down of share capital registered 31 aug 2023 07:00

PCI Biotech first half 2023 interim results 25 aug 2023 14:30

PCI Biotech: Invitation to first half interim 2023 results presentation 25 maj 2023 11:38

Minutes from Annual General Meeting 2023 24 maj 2023 10:43

Disclosure of voting rights for Chairman of the Board 09 maj 2023 15:52

PCI Biotech: Invitation to Q1 2023 results presentation 04 maj 2023 10:04

PCI Biotech - Notice of Annual General Meeting 2023 28 apr 2023 09:59

PCI Biotech Holding ASA: Annual Report 2022 17 feb 2023 07:00

PCI Biotech interim Q4 2022 results 13 feb 2023 15:35

PCI Biotech: Invitation to Q4 2022 results presentation 20 jan 2023 12:37

Flaggemelding relatert til PCIB 25 nov 2022 18:08

PCI Biotech: Employee share option scheme 23 nov 2022 07:00

PCI Biotech interim Q3 2022 report 17 nov 2022 17:42

PCI Biotech: Invitation to Q3 2022 results presentation 08 sep 2022 11:58

Correction: PCI Biotech: Mandatory notification regarding trade of shares 08 sep 2022 11:03

PCI Biotech: Mandatory notification regarding trade of shares 31 aug 2022 07:00

PCI Biotech interim first-half year 2022 results 26 aug 2022 11:34

PCI Biotech: Invitation to first-half year 2022 results presentation 18 aug 2022 18:05

PCI Biotech: Company update 25 maj 2022 11:47

Minutes from Annual General Meeting 2022 24 maj 2022 10:44

Disclosure of voting rights for Chairman of the Board 11 maj 2022 07:00

PCI Biotech interim first quarter 2022 results 09 maj 2022 08:45

PCI Biotech to present at TIDES USA 2022 04 maj 2022 15:10

PCI Biotech: Invitation to Q1 2022 results presentation 04 maj 2022 11:00

Notice of Annual General Meeting 2022 28 apr 2022 10:59

PCI Biotech Holding ASA publishes the Annual Report 2021 28 mar 2022 14:21

PCI Biotech: CEO resigns to assume new position 18 feb 2022 07:00

PCI Biotech fourth quarter and preliminary full year 2021 results 14 feb 2022 12:50

PCI Biotech: Invitation to Q4 2021 result presentation 24 jan 2022 21:00

PCI Biotech: Update on the RELEASE trial 11 jan 2022 09:01

PCI Biotech: Publication of preclinical tuberculosis results 05 jan 2022 07:00

PCI Biotech and MDimune announce research collaboration agreement 14 dec 2021 11:45

PCI Biotech to present at DNB Nordic Healthcare Conference 2021 13 dec 2021 17:12

PCI Biotech: Independent Data Monitoring Committee recommends continuation of two treatments in the RELEASE trial 07 dec 2021 18:45

PCI Biotech: Update on regulatory interactions for the RELEASE trial 30 nov 2021 08:00

PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments 29 nov 2021 11:07

PCI Biotech to present at ABGSC Nordic Rare Disease Seminar 17 nov 2021 07:00

PCI Biotech Q3 2021 interim results 09 nov 2021 12:50

PCI Biotech: Invitation to Q3 2021 result presentation 09 nov 2021 09:30

PCI Biotech to present at the 9th International mRNA Health Conference 08 nov 2021 11:15

PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series 06 sep 2021 18:20

PCI Biotech: Employee share option scheme 31 aug 2021 07:00

PCI Biotech first half-year 2021 interim results 23 aug 2021 10:00

PCI Biotech: Invitation to first half-year 2021 result presentation 31 maj 2021 11:16

PCI Biotech: US patent for the vaccine technology (fimaVacc) in combination with checkpoint inhibitors 28 maj 2021 14:51

PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer 28 maj 2021 11:24

PCI Biotech Minutes from Annual General Meeting 2021 27 maj 2021 09:02

Disclosure of voting rights for Chairman of the Board 07 maj 2021 12:51

PCI Biotech: Notice of Annual General Meeting 2021 07 maj 2021 07:00

PCI Biotech first quarter 2021 interim results 05 maj 2021 11:00

OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies 30 apr 2021 21:00

PCI Biotech: First US patient enrolled in the fimaChem pivotal RELEASE study 30 apr 2021 11:00

PCI Biotech: Invitation to first quarter 2021 results presentation 21 apr 2021 09:05

PCI Biotech Holding ASA publishes the Annual Report 2020 06 apr 2021 12:30

PCI Biotech to present at European Biotech Investor Days 2021 24 feb 2021 07:00

PCI Biotech fourth quarter and preliminary full year 2020 results